Democrats Choosing Less Risky Path on Drug Prices November 8, 2021 Auto Bot Biotechnology and Bioengineering, Democratic Party, Health Insurance and Managed Care, House of Representatives, Law and Legislation, Medicare, Prices (Fares, Fees and Rates), Regulation and Deregulation of Industry, United States Politics and Government 0 Experts say recent compromises could create less harm in balancing innovation with profits.